These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28154102)

  • 1. Cryptogenic Stroke: Research and Practice.
    Yaghi S; Bernstein RA; Passman R; Okin PM; Furie KL
    Circ Res; 2017 Feb; 120(3):527-540. PubMed ID: 28154102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
    Roth C; Alli O
    Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study.
    Yaghi S; Boehme AK; Hazan R; Hod EA; Canaan A; Andrews HF; Kamel H; Marshall RS; Elkind MS
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):110-4. PubMed ID: 26476588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioembolic Stroke.
    Kamel H; Healey JS
    Circ Res; 2017 Feb; 120(3):514-526. PubMed ID: 28154101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines.
    Ratajczak-Tretel B; Lambert AT; Atar D; Aamodt AH
    Acta Neurol Scand; 2022 May; 145(5):641-646. PubMed ID: 35146751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
    Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
    Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
    Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
    JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close.
    Messé SR; Kasner SE
    Circulation; 2008 Nov; 118(19):1999-2004. PubMed ID: 18981314
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke of undetermined cause: workup and secondary prevention.
    Weimar C
    Curr Opin Neurol; 2016 Feb; 29(1):4-8. PubMed ID: 26641813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke Prevention After Cryptogenic Stroke.
    Ibeh C; Elkind MSV
    Curr Cardiol Rep; 2021 Oct; 23(12):174. PubMed ID: 34657187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cryptogenic stroke and patent foramen ovale].
    Windecker S; Nedeltchev K; Wahl A; Meier B
    Ther Umsch; 2003 Sep; 60(9):553-61. PubMed ID: 14579624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of frequencies of patent foramen ovale and thoracic aortic atherosclerosis in patients with cryptogenic ischemic stroke undergoing transesophageal echocardiography.
    Gu X; He Y; Li Z; Kontos MC; Paulsen WH; Arrowood JA; Nixon JV
    Am J Cardiol; 2011 Dec; 108(12):1815-9. PubMed ID: 21889761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A; Ekmejian A; Collins N; Bhagwandeen R
    Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.